Cargando…
Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial
BACKGROUND: Safe and effective vaccines are urgently needed to end the COVID-19 pandemic caused by SARS-CoV-2 infection. We aimed to assess the preliminary safety, tolerability, and immunogenicity of an mRNA vaccine ARCoV, which encodes the SARS-CoV-2 spike protein receptor-binding domain (RBD). MET...
Autores principales: | Chen, Gui-Ling, Li, Xiao-Feng, Dai, Xia-Hong, Li, Nan, Cheng, Meng-Li, Huang, Zhen, Shen, Jian, Ge, Yu-Hua, Shen, Zhen-Wei, Deng, Yong-Qiang, Yang, Shu-Yuan, Zhao, Hui, Zhang, Na-Na, Zhang, Yi-Fei, Wei, Ling, Wu, Kai-Qi, Zhu, Meng-Fei, Peng, Cong-Gao, Jiang, Qi, Cao, Shou-Chun, Li, Yu-Hua, Zhao, Dan-Hua, Wu, Xiao-Hong, Ni, Ling, Shen, Hua-Hao, Dong, Chen, Ying, Bo, Sheng, Guo-Ping, Qin, Cheng-Feng, Gao, Hai-Nv, Li, Lan-Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786321/ https://www.ncbi.nlm.nih.gov/pubmed/35098177 http://dx.doi.org/10.1016/S2666-5247(21)00280-9 |
Ejemplares similares
-
Neutralization of ARCoV-induced sera against SARS-CoV-2 variants
por: Li, Xiao-Feng, et al.
Publicado: (2022) -
Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine
por: Zeng, Guangting
Publicado: (2022) -
A high-performance trace level acetone sensor using an indispensable V(4)C(3)T(x) MXene
por: Zhao, Wei-Na, et al.
Publicado: (2020) -
Multi-omics analysis reveals a molecular landscape of the early recurrence and early metastasis in pan-cancer
por: He, Dan-ni, et al.
Publicado: (2023) -
Integration of multi-omics data reveals a novel hybrid breast cancer subtype and its biomarkers
por: Wang, Zhen-zhen, et al.
Publicado: (2023)